Meeting
2015 Genitourinary Cancers Symposium
A biomarker panel associated with distant metastasis in prostate cancer patients treated with radiotherapy as prognostic for DM in a large cohort of prostatectomy patients.
Authors
Alan Pollack
Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL
Alan Pollack , Nicholas Erho , Roshan Noronha , Lucia L.C. Lam , Christine Buerki , Sakhi Abraham , Eric A. Klein , R. Jeffrey Karnes , Robert Benjamin Den , Adam Dicker , Adrian Ishkanian , Elai Davicioni , Felix Yi-Chung Feng , Radka Stoyanova
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 8)
DOI
10.1200/jco.2015.33.7_suppl.8
Abstract #
8
Poster Bd #
A14
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Independent blinded validation of an AI-based digital histology classifier for prostate cancer recurrence and metastasis risk prediction.
First Author: Magdalena Fay
Poster
2023 ASCO Genitourinary Cancers Symposium
Urinary proteome as a prognostic factor in the deterioration of the quality of life of patients with localized prostate cancer during radiotherapy: Radiotoxicity Bladder Biomarkers (RABBIO) prospective trial.
First Author: Carole Helissey
Poster
2023 ASCO Genitourinary Cancers Symposium
Validation of baseline health-related quality of life as prognostic indicator for survival outcome in men with intermediate risk prostate cancer undergoing radical prostatectomy.
First Author: Thilo Westhofen
Poster
2022 ASCO Genitourinary Cancers Symposium
BCG efficacy in nonmuscle-invasive bladder cancer after prior radiation treatment for prostate cancer.
First Author: Adri Durant